With the analysis among 1,710 patents, we discovered top 258 key players by total patent application. Janssen Pharmaceutica NV, Five Prime Therapeutics, Inc., Novartis AG are dominant in this area. They take 15.85% of the total patent filing.
Antwerpen, Belgium
Patent: 115
Five Prime Therapeutics, Inc.
California, United States
Patent: 82
Basel-Stadt, Switzerland
Patent: 74
Indiana, United States
Patent: 74
Delaware, United States
Patent: 72
Blueprint Medicines Corp.
Massachusetts, United States
Patent: 56
California, United States
Patent: 55
New York, United States
Patent: 41
New York, United States
Patent: 39
With the analysis among 83 patents, we discovered top 10 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, TransThera Sciences (Nanjing), Inc., Trefoil Therapeutics, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
TransThera Sciences (Nanjing), Inc.
Jiangsu Sheng, China
Patent: 5
Trefoil Therapeutics, Inc.
California, United States
Patent: 4
Juvena Therapeutics, Inc.
California, United States
Patent: 3
Niedersachsen, Germany
Patent: 2
Texas, United States
Patent: 2
National Institutes for Quantum & Radiological Science & Tech
Chiba-ken, Japan
Patent: 2
Cloudbreak Therapeutics LLC
California, United States
Patent: 2
Epsilon Molecular Engineering, Inc.
Saitama-ken, Japan
Patent: 1
With the analysis among related 448 patents applied in the last 5 years. We discover 105 most active companies in this area. The fast-growing Janssen Pharmaceutica NV, Incyte Corp., Five Prime Therapeutics, Inc. take 36.38% of patent filing during this period.
Antwerpen, Belgium
Patent: 83
Delaware, United States
Patent: 50
Five Prime Therapeutics, Inc.
California, United States
Patent: 30
Betta Pharmaceuticals Co., Ltd.
Zhejiang Sheng, China
Patent: 26
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 21
Mitsubishi Tanabe Pharma Corp.
Osaka-fu, Japan
Patent: 16
New York, United States
Patent: 15
Centre National De La Recherche Scientif
With the analysis among related 448 patents in last 5 years, we discover 69 new entrants. Betta Pharmaceuticals Co., Ltd., Kinnate Biopharma, Inc., Mitsubishi Tanabe Pharma Corp. are the most active new entrants in this area.
Betta Pharmaceuticals Co., Ltd.
Zhejiang Sheng, China
Patent: 26
California, United States
Patent: 21
Mitsubishi Tanabe Pharma Corp.
Osaka-fu, Japan
Patent: 16
North Carolina, United States
Patent: 10
Taiho Pharmaceutical Co., Ltd.
Zug, Switzerland
Patent: 6
Guangdong Sheng, China
Patent: 6
Jiangsu Kaiyuan Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 5
Regents of The University of Michigan
Michigan, United States
Patent: 4
With the analysis among 467 patents, we discovered top 65 universities and scientific research institutions by total patent application. The Salk Institute for Biological Studies, Université Côte dAzur, Université Toulouse III - Paul Sabatier are dominant in this area. They take 29.98% of the total patent filing.
The Salk Institute for Biological Studies
California, United States
Patent: 46
Université Toulouse III - Paul Sabatier
New York, United States
Patent: 15
Vrije Universiteit Brussel
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 13
Kyoto-fu, Japan
Patent: 12
Zhejiang Sheng, China
Patent: 12
Vlaams Instituut voor Biotechnologie - Flanders Institute
Hovedstaden, Denmark
Patent: 10
The University of Queensland
Queensland, Australia
Patent: 8